This new functionality enables raw sequencing data analysis for Gene Panels (GP), Whole Exome (WES) and Whole Genome (WGS).

eVai now delivers: 

• variant detection accuracy above 99%;

• award winning variant interpretation leveraging genomic, family and clinical data; 

• short processing time - hours for WES and 4 hours for WGS;

• 100% reproducibility;

• population genomics scalability.

“eVai’s improvements have always been user-centric and this technological advancement that will enable end-to-end analysis is our answer to the requests received. We see that as an important milestone to further drive eVai adoption and make its unique variant interpretation available to a broader audience ”, says Ettore Rizzo, CEO and Co-Founder of the company.

From a technical perspective the workflow performs reads mapping, variant calling and variant filtering. Coverage and Gap analysis are executed and a complete Quality Control report is generated to give a full picture of the analysis executed. The VCF file generated as output is automatically interpreted. 

Press Contact: Giovana Herold - gherold@engenome.com